Extended list of
our Products
"The best way to predict the future is to create it"
Abraham Lincoln
this is what we do

Our mission in PharOS is to materialize in the most efficient way our customers trust, by ensuring that their products will be among

the first to be launched after patent expiry and the last ones to exit the market.

ACTIVE INGREDIENT
THERAPEUTIC CATEGORY
DELIVERY FORM
STRENGTH(S)
PREVIEW
DARUNAVIR
Antivirals
FILM COATED TABLET
75mg, 150mg, 300mg, 400mg, 600mg, 800mg
DARUNAVIR
ENLARGE
VILDAGLIPTIN
Antidiabetics
TABLET
50mg
VILDAGLIPTIN
ENLARGE
ENTECAVIR
Antivirals
FILM COATED TABLET
0.5mg, 1mg
ENTECAVIR
ENLARGE
FEBUXOSTAT
Hyperuricemia
FILM COATED TABLET
80mg, 120mg
FEBUXOSTAT
ENLARGE
EFAVIRENZ/EMTRICITABINE/TENOFOVIR
Antivirals
Film Coated Tablet
600mg/200mg/245mg
EFAVIRENZ/EMTRICITABINE/TENOFOVIR
ENLARGE
IVABRADINE
CVS
Film Coated Tablet
5mg, 7.5mg
IVABRADINE
ENLARGE
ERLOTINIB
Oncology
Film Coated Tablet
25mg, 50mg, 100mg, 150mg
ERLOTINIB
ENLARGE
* Availability of products is subject to patent restrictions in countries where applicable patents are in effect. Exclusivity restrictions may apply.
CONTACT
businessdevelopment
@pharosgr.gr
For our current
product pipeline